Reference : Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP...
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/12372
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia
English
Archimbaud, E. [ > > ]
Jehn, U. [ > > ]
Thomas, X. [ > > ]
De Cataldo, F. [ > > ]
Fillet, Georges mailto [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale >]
Belhabri, A. [ > > ]
Peaud, P.-Y. [ > > ]
Martin, C. [ > > ]
Amadori, S. [ > > ]
Willemze, R. [ > > ]
1999
Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K
Nature Publishing Group
13
843-849
Yes (verified by ORBi)
0887-6924
1476-5551
London
United Kingdom
[en] elderly AML ; treatment ; triple drug induction ; idarubicin vs mitoxantrone ; PBSC transplantation
http://hdl.handle.net/2268/12372

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
143.pdfPublisher postprint102.72 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.